As countries like the United States and United Kingdom inoculate their residents with never-before used vaccine technology, others, including Russia, China, and India, are investing in more traditional approaches, like inactivated coronavirus vaccines. But no matter the technique, together they have the potential to create multiple lines of defense against SARS-CoV-2. Science senior correspondent Jon Cohen explains how each of these vaccines can protect us from severe illness—and what understanding the details of our immune responses could mean for the future of human trials.
Tag Archives: Covid-19 Vaccines
Morning News Podcast: New Covid-19 Variant & Vaccines, California Cases
A new variant of the coronavirus has scientists worried about the effectiveness of COVID-19 vaccines. In California, Gov. Gavin Newsom has lifted regional stay-at home orders.
But 54 counties in the state are still classified as having “widespread” coronavirus risk. So why did the state loosen the restrictions? And the CDC is reporting the highest number of overdoses in a 12-month period.
Morning News Podcast: President Biden’s First Day, Covid Actions & Numbers
President Biden’s top priority is getting the pandemic under control. What do his first executive actions tell us about how he plans to do that? Biden also released a sweeping reform bill to overhaul the U.S. immigration system.
And in 35 states, coronavirus numbers are falling. Researchers believe the U.S. has hit a peak in the pandemic, but some public health officials are skeptical.
Covid-19: ‘The Rise Of The RNA Vaccines’ (Podcast)
Benjamin Thompson, Noah Baker and Elie Dolgin discuss RNA vaccines.
In this episode:
01:16 How RNA vaccines came to prominence
In less than a year, two RNA vaccines against COVID-19 were designed, tested and rolled out across the world. We discuss these vaccines’ pros and cons, how RNA technology lends itself to rapid vaccine development, and what this means for the fight against other diseases.
News feature: How COVID unlocked the power of RNA vaccines
09:20 The hurdles for trialling new COVID-19 vaccines
Multiple candidates for new COVID-19 vaccines are still being developed, which may offer advantages over the vaccines currently available. However, running placebo-controlled trials of these candidates is becoming increasingly difficult, so researchers are looking for different ways to evaluate them.
News: Search for better COVID vaccines confounded by existing rollouts
14:45 How long will COVID vaccines be effective?
There is much concern around the world about two faster-spreading variants of SARS-CoV-2. We get an update on whether these variants could render vaccines ineffective.
News: Could new COVID variants undermine vaccines? Labs scramble to find out
Covid-19 Podcast: Latest On Vaccine Rollout, New Mutation & FDA Approvals
Stephen Hahn, U.S. Food and Drug Administration Commissioner, Sigal Atzmon, founder and chief executive officer of Medix Global, and Roche CEO Severin Schwan, on the pandemic, Covid-19 vaccines and the new mutation.
Infographic: ‘Pfizer’s Vaccine Ingredients & Treatment Information’
Morning News Podcast: Biden Win Now Official, Vaccine Costs To States
Joe Biden officially captures enough electoral votes to win the presidency, William Barr to resign as Attorney General, and Florida man pays neighbors’ utility bills for 2nd straight Christmas.
Covid-19 Infographic: One-Year Progress Of Treatments & Vaccines
Covid: China Vaccinates One Million People (Video)
One year since the outbreak emerged in Wuhan, China says it has vaccinated nearly one million people against Covid-19. FRANCE 24 correspondent Charles Pellegrin says while the vaccines have yet to be fully approved for market, authorities have granted permission for their limited use on selected groups of the population.
Morning News Podcast: Presidential Transition Begins, Covid-19 Vaccines
Presidential transition process to begin after weeks of delay, Biden picks Janet Yellen for Treasury Secretary, and holiday shopping is different this year.
Boomers Daily 